Vitreoretinal

Caroline Baumal, M.D.

Caroline Baumal, M.D.

Caroline R. Baumal, MD is a Professor of Ophthalmology at Tufts Medical Center and co-director of the retina service and medical retina fellowship at New England Eye Center in Boston, MA. She specializes in medical and surgical diseases of the retina and vitreous. Her research interests include novel retinal imaging and drug development, which are a continuation from her research background with the prototype OCT and working with drug implants and photodynamic therapy. Her clinical interests include age-related macular degeneration, diabetic retinopathy, retinal circulatory disorders, complex vitreoretinal surgery, and retinopathy of prematurity (ROP).

Dr. Baumal completed medical school and ophthalmology residency at the University of Toronto after undergraduate studies at McGill University. She completed two fellowships: one at New England Eye Center, Boston in Medical Retina and Lasers and another in Vitreoretinal Diseases and Surgery at Wills Eye Hospital in Philadelphia. Dr. Baumal is Board Certified by the American Board of Ophthalmology. She has received multiple awards from various societies including the American Academy of Ophthalmology, The American Society of Retinal Surgeons, The Retinal Hall of Fame, the Donald J. Gass Beacon of Sight Award from the Florida Ophthalmologic Society, the ASRS Crystal Apple award and was recently awarded the Lifetime Achievement award from the Vit-Buckle Society. She is on the editorial board for Retina Cases and Brief Reports and Ophthalmic Surgery, Lasers, and Imaging (OSLI) Retina. Dr. Baumal has authored over 170 publications, 33 book chapters on retinal diseases and edited the book Treatment of Diabetic Retinopathy. She is actively involved in mentoring and teaching vitreoretinal fellows and residents and was previously Director of Education and the Residency program at New England Eye Center.

David Boyer, M.D.

David Boyer, M.D.

David S. Boyer, M.D., is a board-certified ophthalmologist specializing in the treatment of retinal and vitreous diseases. He is a Senior Partner at Retina-Vitreous Associates Medical Group. Dr. Boyer earned his medical degree at Chicago Medical School, completed his internship and residency at the University of Southern California/Los Angeles County Medical Center, and completed his fellowship in retinal surgery at the Wills Eye Hospital in Philadelphia. Dr. Boyer is a clinical professor of ophthalmology at the Keck School of Medicine of the University of Southern California and has an extensive research background. He is one of the leading retinal clinical researchers in the country for new treatments in macular degeneration and diabetic macular edema. Dr. Boyer is a widely-published author and avid lecturer who lectures internationally on retinal research and innovative approaches to the treatment of retinal disease. He has authored and co-authored numerous works in peer-reviewed journals and has served as a reviewer for ophthalmology and diabetes medical publications, including Archives of Ophthalmology, American Journal of Ophthalmology, and Ophthalmology.

David Brown, M.D., F.A.C.S

David Brown, M.D., F.A.C.S

David Brown, M.D. F.A.C.S. is the director of research at Retina Consultants of Texas, chair of the Medical Leadership Board of Retina Consultants of America (RCA), and a member of the RCA board of directors. Additionally, Dr. Brown is a Clinical Professor of Ophthalmology at Baylor College of Medicine, vice-chair for research for Houston Methodist Hospital, and is a member of NASA’s research and clinical advisory panel. Dr. Brown graduated from Baylor College of Medicine with highest honors and completed ophthalmology and retina training at the University of Iowa. He was a Thomas Heed Fellow, a Hermann Knapp Fellow, and was awarded the Ron Michels Fellowship award presented to the top retinal surgery fellow in the US in 1994.

Dr. Brown is a renowned leader in the retina and has published over 500 national meeting presentations, abstracts, and scientific papers, including many of the primary papers that established the use of anti-VEGF agents for AMD, retinal vein occlusion, and diabetic retinopathy (DR). He serves as a peer-reviewer for 8 ophthalmology journals and has authored 9 book chapters. Dr. Brown is an investigator in Ocuphire’s ZETA-1 Phase 2 clinical trial evaluating the safety and efficacy of oral APX3330 in patients with diabetic retinopathy.

Jeffrey Heier, M.D.

Jeffrey Heier, M.D.

Dr. Heier is the Co-President, Medical Director, Director of the Vitreoretinal Service, and Director of Retina Research at Ophthalmic Consultants of Boston (OCB), one of the largest and most prestigious multi-specialty ophthalmology practices in the United States. He is also on the Executive Board of the Retina Society and the Executive Committee of the American Society of Retina Specialists. He is the Past President of the New England Ophthalmological Society, and is a member of the Macula Society. Dr. Heier has received several awards from the American Academy of Ophthalmology, including the Senior Achievement Award in 2010, the Secretariat Award in 2007, and the Honor Award in 2003. He is also the recipient of the Honor Award and Senior Honor Award from the American Society of Retina Specialists. Dr. Heier is one of the leading retinal clinical researchers in the country for new treatments in exudative and non-exudative macular degeneration, diabetic macular edema, venous occlusive disease, vitreoretinal surgical techniques and instrumentation, and diagnostic imaging of the retina. He is a scientific advisor to several biotechnical or pharmaceutical companies, lectures nationally and internationally, and has authored numerous, peer-reviewed works. Dr. Heier received his medical degree from Boston University, did an internship and residency at Fitzsimons Army Medical Center, and a vitreoretinal fellowship at OCB/Tufts School of Medicine. Dr. Heier served as a physician in a Combat Support Hospital in the Persian Gulf War, where he was awarded a Bronze Star.

David Lally, M.D.

David Lally, M.D.

David Lally, M.D. F.A.S.R.S. is a retina surgeon at Baystate Medical Center, an Assistant Professor of Ophthalmology at the University of Massachusetts Medical School-Baystate, and the director of the Retina Research Institute at New England Retina Consultants. Dr. Lally graduated from Vanderbilt University and received a medical degree from Jefferson Medical College. He completed ophthalmology residency at the Wills Eye Hospital in Philadelphia followed by a vitreoretinal fellowship at Tufts/New England Eye Center and Ophthalmic Consultants of Boston. He is an a is an active member of the American Society of Retina Specialists with the Fellow of the American Society of Retina Specialist (FASRS) award designation.

Dr. Lally’s work has been published in over 25 articles in peer-reviewed ophthalmic journals, and he has delivered over 25 presentations at national meetings. Dr. Lally is part of several clinical trial steering committees and an exceptional recruiter as principal investigator in numerous retina clinical trials. Dr. Lally is an investigator in Ocuphire’s ZETA-1 Phase 2 clinical trial.

Peter K. Kaiser, M.D.

Peter K. Kaiser, M.D.

Peter K. Kaiser, M.D., is a clinical research expert, serving as Study Chairman of 5 major, multi-center, international clinical trials, and principal investigator in numerous studies for AMD, DR, and other retinal disorders. He is the founder and director of the Digital Optical Coherence Tomography Reading Center (DOCTR), Editor-in-Chief of Retinal Physician, Associate Editor of International Ophthalmology Clinics, and serves on the editorial boards of Retina, Retina Today, and Ocular Surgery News. He is a National Institute of Health (NIH) funded investigator, leading a team involved in the evaluation of vascular biology in age-related macular degeneration and diabetic retinopathy. Dr. Kaiser serves on numerous scientific advisory boards and addresses his research interests as an invited speaker at national and international conferences. He is a major contributor to the medical literature having authored 7 textbooks, and more than 250 peer-reviewed papers, and has been recognized by the American Academy of Ophthalmology and American Society of Retina Specialists with Senior Achievement Awards and is listed as one of the “Best Doctors in America.” Dr. Kaiser graduated magna cum laude with Highest Honors from Harvard College and Harvard Medical School. He completed an ophthalmology residency at the Massachusetts Eye and Ear Infirmary, and a vitreoretinal fellowship at Bascom Palmer Eye Institute before joining the vitreoretinal department of the Cole Eye Institute, Cleveland, Ohio.    

Arshad M. Khanani, MD, MA, FASRS

Arshad M. Khanani, MD, MA, FASRS

Arshad M. Khanani, MD, MA, FASRS is a Managing Partner, Director of Clinical Research, and Director of Fellowship at Sierra Eye Associates and Clinical Associate Professor at the University of Nevada, Reno School of Medicine. Dr. Khanani founded the clinical research department at Sierra Eye Associates, which is now one of the leading clinical research centers in the country. He has served as a principal investigator for over 120 clinical trials and has been a top enroller in the country for multiple Phase 1-3 trials. Dr. Khanani also serves as a member of numerous national and international clinical trial steering committees as well as scientific advisory boards with the goal of bringing new treatment options for patients with retinal diseases. He has authored over 100 publications in prominent ophthalmology journals. Dr. Khanani is an elected member of the Macula Society, Retina Society and has received numerous awards of distinction.  In 2019, he received the Nevada Business Magazine Healthcare Heroes Physician of the Year award for his continued dedication to the field of ophthalmology. He has received the Senior Honor Award from the American Society of Retina Specialists (ASRS) and was also awarded the prestigious ASRS Presidents’ Young Investigator Award in 2021.

Anat Lowenstein, M.D., Ph.D.

Anat Lowenstein, M.D., Ph.D.

Anat Loewenstein, MD, Professor of Ophthalmology, Vice Dean of the Faculty of Medicine, and Sidney Fox Chair of Ophthalmology at the Sackler Faculty of Medicine at the Tel Aviv University, Chairman of the Department of Ophthalmology, Tel Aviv Medical Center. Completed residency in the Department of Ophthalmology at the Tel Aviv Medical Center, fellowship in vitreoretina at the Wilmer Institute, Johns Hopkins University Hospital in Baltimore. Is Chairman of the Department of Ophthalmology at the Tel Aviv Medical Center since 2000. Completed a Master of Health Administration degree at the Tel Aviv University Business School. Is involved in the development of multiple innovative efforts, was the leader behind the development of novel technology for early detection of macular degeneration, as well as recently, the development of automated technology for detection of retinal disease activity and the development of augmented virtual reality to replace the operating microscope. Published more than 380 papers in peer reviewed journals, and contributed multiple chapters to ophthalmology textbooks. Has multiple roles in most prominent retina societies. Is active at most international retina meetings and is an invited speaker in most. Serves as the Editor of the Journal Case Reports in Ophthalmology, is an associate Serves as the chair of the Ministry of Health’s ethics committee and is a member of the National Council of Surgery and anesthesia. Received multiple international awards in most prestigious societies.

Carl D. Regillo, MD, FASRS

Carl D. Regillo, MD, FASRS

Dr. Carl D. Regillo is Professor of Ophthalmology at Thomas Jefferson University, Chief of the Retina Service of Wills Eye Hospital and Founder of the Wills Eye Clinical Retina Research Unit in Philadelphia.  He received his medical degree from Harvard Medical School and performed his ophthalmology residency and vitreoretinal fellowship at Wills Eye Hospital.  He has authored over 300 publications along with over 50 book chapters and 9 major books.  He has been an investigator on numerous major clinical trials developing new medical and surgical treatments for retinal disorders such as macular degeneration and diabetic retinopathy.   He is invited to lecture worldwide and serves on the scientific editorial board for several top ophthalmology peer-reviewed journals.  As a recognized leader in the field, he is a recipient of the many local, national, and international awards including American Academy of Ophthalmology Achievement, Senior Achievement, Secretariat, and Lifetime Achievement Awards and the American Society of Retinal Specialists Honor, Senior Honor, Presidential, and Founders Awards.  He was charter inductee of the Retina Hall of Fame and named in the Ophthalmologist Power List of the top 100 most influential ophthalmologists in the world.  He was also listed among the top 150 ophthalmologists in the US by Newsweek.

Rishi P. Singh, MD

Rishi P. Singh, MD

Dr. Rishi P. Singh MD is a staff surgeon and vice-president/chief medical offier of Clevealnd Clinic Martin Health in Stuart Florida, and Professor of Ophthalmology at the Lerner College of Medicine in Cleveland Ohio. He received his bachelor’s and medical degrees from Boston University and completed his residency at the Massachusetts Eye and Infirmary Harvard Combined Program in Boston, Massachusetts. Dr. Singh then completed a medical and surgical fellowship at the Cole Eye Institute in Cleveland, Ohio.

He specializes in the treatment of medical and surgical retinal disease such as diabetic retinopathy, retinal detachment, and age-related macular degeneration. Dr. Singh has authored more than 250 peer reviewed publications, books, and book chapters and serves as the principal investigator of numerous national clinical trials advancing the treatment of retinal disease.

Charles C. Wykoff, MD, PhD, FACS, FASRS

Charles C. Wykoff, MD, PhD, FACS, FASRS

Dr. Charles C. Wykoff is a board-certified Medical and Surgical Retina Specialist and ophthalmologist with Retina Consultants of Texas (RCTX). Leading a top international research facility for vitreoretinal diseases, Dr. Wykoff serves as Director of Research at RCTX and Chairman of the Research and Clinical Trials Committee, Retina Consultants of America. He is also Professor of Clinical Ophthalmology and Deputy Chair of Ophthalmology, Blanton Eye Institute, Houston Methodist Hospital.

 Dr Wykoff is a member of the NEI Audacious Goals Steering Committee and has been awarded multiple Achievement, Honor and Senior Honor Awards including the ASRS Young Investigator and the AAO Secretariat Awards.

Anterior Segment and Refractive

Zaina Al-Mohtaseb, M.D.

Zaina Al-Mohtaseb, M.D.

Dr. Zaina Al-Mohtaseb is a board-certified ophthalmologist and surgeon, specializing in cataractLASIK, and cornea surgery for Whitsett Vision Group patients, as well as comprehensive ophthalmology.

She earned her medical degree with honors from Baylor College of Medicine and completed her ophthalmology residency at the Cullen Eye Institute at Baylor where she was elected Chief Resident. She finished her training and fellowship at the University of Miami’s Bascom Palmer Eye Institute.

Dr. Al-Mohtaseb is a key opinion leader in ophthalmology and an adopter of new surgical techniques and ophthalmic technologies. She has authored multiple scientific publications and presents numerous lectures nationally and internationally. She has a clinical Associate Professor appointment at Baylor College of Medicine and was the previous Associate Program Director of Residency. She will lead continued clinical research initiatives at Whitsett Vision Group as the Director of Research. She is recognized as an expert in complex vision correction surgery, Dr. Al-Mohtaseb performs the full spectrum of procedures including cataract surgery, LASIK & PRK & ICL, presbyopia correction, DSEK & DMEK, Collagen Cross-Linking, & secondary intraocular lenses & IOL exchanges.

She is an active member of numerous ophthalmic societies and is the Chair of the American Society of Cataract and Refractive Surgery Young Eye Surgeon committee which serves to educate young surgeons nationally and internationally through lectures, webinars, and wet labs. She has also won numerous awards including “Top Doctors,” BCM Women of Excellence Award & Excellence in Patient Care, the National Award Outstanding Leader in Ophthalmology, the National Award Rising Star in Ophthalmology, the national AAO Achievement Award, and most recently the international award Ophthalmology’s Power List – Top 100 ophthalmologists & Ophthalmology Management’s National Top 40 Under 40 award.

Y. Ralph Chu, M.D.

Y. Ralph Chu, M.D.

Y. Ralph Chu, M.D. is the CEO and Chief Medical Officer of the Chu Vision Institute and Chu Surgery Center in Minnesota. Dr. Chu earned his medical degree from Northwestern University in Chicago where he was a member of the Alpha Omega Alpha Honor Society. He completed his internship at Evanston Hospital, followed by a residency in ophthalmology at Duke University Eye Center. He furthered his medical training with a one-year fellowship in Minneapolis where he specialized in cornea and external disease, refractive, glaucoma, cataract, and lens implant surgery.

Dr. Chu is an internationally recognized leader, innovator, and pioneer of new technologies in cataract and refractive surgery and has been involved in over 95 clinical trials across various ophthalmic diseases. He has published over 100 national meeting presentations, abstracts, and scientific papers. Dr. Chu has also been a member of several product launch committees for refractive surgery products. Dr. Chu is a clinical investigator in Ocuphire's MIRA-3 Phase 3 clinical trial evaluating the safety and efficacy of Nyxol for reversal of mydriasis.

Mitchell A. Jackson, M.D.

Mitchell A. Jackson, M.D.

Mitchell A. Jackson, M.D. is the founder and CEO of Jacksoneye in Illinois and has practiced as a comprehensive ophthalmologist for 28 years. He graduated from Pomona College, completed his medical training at FUHS/The Chicago Medical School, and completed his Ophthalmology residency at the University of Chicago Hospitals. Dr. Jackson has been involved in over 40 pharmaceutical and surgical device clinical studies, including several presbyopia studies. Dr. Jackson serves on 7 editorial advisory boards, including Presbyopia Physician. Dr. Jackson serves as a member of the medical advisory board of several companies, and a speaker for some of the largest ophthalmic companies. Dr. Jackson has been voted Best Cataract Surgeon in America 2021 as well as a Top 50 global Key Opinion Leaders (KOL). He is a clinical investigator in Ocuphire's MIRA-3 Phase 3 clinical trial.

James A. Katz, M.D.

James A. Katz, M.D.

James A. Katz, M.D. is a board-certified ophthalmologist and president of the Midwest Center for Sight. He is a graduate of the University of Illinois Chicago, College of Medicine. He completed his internship at Illinois Masonic Medical Center with his residency at the University of Illinois Eye & Ear Infirmary. He completed a prestigious fellowship at Casebeer International Eye Center and the University of Utah Moran Eye Center.

Dr. Katz specializes in cornea, cataract, and refractive surgery and is well-published in distinguished ophthalmologic journals with over 50 publications and over 300 presentations. He is an editorial board member of ophthalmology publications, including Cataract & Refractive Surgery Today and Presbyopia Physician. Dr. Katz has been a principal investigator in numerous FDA trials including several studies for the treatment of presbyopia. Dr. Katz speaks and teaches nationally and internationally on cataract, presbyopia and refractive surgery, and has received several notable awards and distinctions including the American Academy of Ophthalmology Achievement Award and the CEDARS ASPENS Founders Award.

Eliot Lazar, M.D.

Eliot Lazar, M.D.

Eliot Lazar, M.D., is a clinical ophthalmologist who serves as the President of elCON Medical Consulting and the Principal of elCON Medical in Buffalo, New York. Dr. Lazar has extensive experience in the commercial side of ophthalmology and other specialties. He has worked broadly in the development of devices, therapeutics, and diagnostics, and has participated in many of the critical drug delivery advances in ophthalmology and other specialties. Dr. Lazar has also collaborated with financial institutions of all sizes and scopes on both due diligence as well as at the board of directors level. Dr. Lazar has worked collaboratively with both local and global organizations on endeavors from the pre-clinical stage through the commercial stage. Dr. Lazar holds a B.S. from the University of Pennsylvania, an M.S. in Immunology from the Royal College of Surgeons, Trinity College, and the State University of New York, and an M.D. from Georgetown University School of Medicine.

Marguerite McDonald, M.D., F.A.C.S.

Marguerite McDonald, M.D., F.A.C.S.

Marguerite McDonald, M.D., F.A.C.S., is a board-certified ophthalmologist. She received her medical degree from Columbia University College of Physicians and Surgeons and completed her internship at Lenox Hill Hospital, ophthalmology residency at Manhattan Eye Ear and Throat Hospital/Cornell, and a fellowship in corneal and external diseases at the LSU Eye Center. From 1993 to 2005, Dr. McDonald served as the director of the Southern Vision Institute in New Orleans. She is a clinical professor of ophthalmology at the NYU School of Medicine and an clinical professor of ophthalmology at Tulane University Health Sciences Center. Dr. McDonald was a professor of ophthalmology and the director of the Corneal Service at the LSU Eye Center, LSU Medical Center School of Medicine. She performed the world’s first excimer laser treatment to eliminate or reduce the need for glasses and contact lenses as well as the world’s first excimer laser surgeries for farsightedness. She was also the first North American surgeon to perform Epi-LASIK. Dr. McDonald also performed the first EBK procedure (epi-Bowman’s keratectomy) in the Americas. Dr. McDonald has over 1,800 publications, has received many awards, and has served on the editorial boards of several publications, including the Journal of Cataract and Refractive Surgery and the Journal of Refractive Surgery. She was elected the first female president of the American Society of Cataract and Refractive Surgery (ASCRS) for the 2002-03 term. In 2009-10, Dr. McDonald served as the first female president of the International Society of Refractive Surgery of the American Academy of Ophthalmology (ISRS/AAO).

Jay Pepose, M.D., Ph.D.

Chief Medical Advisor

Jay Pepose, M.D., Ph.D.

Jay Pepose, M.D., Ph.D.

Chief Medical Advisor

Dr. Jay Pepose is a recognized thought leader in the field of ophthalmology, with nearly 40 years of experience as both a treating physician and a widely published researcher. He is the founder and the current Medical Director of the Pepose Vision Institute, and also founded the Midwest Corneal Research Foundation, now the Midwest Vision Research Foundation, as an independent spinout of the Pepose Vision Institute. He is a professor of clinical ophthalmology and visual sciences at Washington University School of Medicine in St. Louis, where he is a specialist in refractive surgery and corneal and external diseases. Dr. Pepose is also a consultant to the Centers for Disease Control and Prevention.

Dr. Pepose is actively involved in clinical research trials and has been the recipient of R-01 grant support from the National Eye Institute. He has served on the editorial boards of several prestigious journals, including the American Journal of Ophthalmology, Investigative Ophthalmology & Visual Science (IOVS), Cornea, and The Journal of Refractive Surgery. He has published over 210 peer-reviewed articles and a book on ocular infections and inflammatory diseases. Since 1990, Dr. Pepose has also served as an investigator on over 30 separate clinical trials, evaluating new therapeutics and technology across a broad range of ophthalmic indications, including adenoviral and bacterial conjunctivitis, meibomian gland dysfunction, dry eye disease, open-angle glaucoma, ocular hypertension, anterior uveitis, and reversal of presbyopia.

Dr. Pepose received an A.B. and M.A. in neurophysiology from Brandeis University and completed the M.D.-Ph.D. program at the UCLA School of Medicine. He completed his ophthalmology residency at the Wilmer Institute at the Johns Hopkins Medical Center and his fellowship training at Georgetown University Medical Center.

Thomas W. Samuelson, M.D.

Thomas W. Samuelson, M.D.

Thomas W. Samuelson, M.D., is a board-certified ophthalmologist who specializes in the treatment of glaucoma, cataract, and refractive surgery, as well as a founding partner and attending surgeon of Minnesota Eye Consultants. Dr. Samuelson completed his medical degree at the University of Minnesota, his residency training at the University of South Florida where he served as chief resident, and his sub-specialty training at the Wills Eye Hospital in Philadelphia. Dr. Samuelson is an adjunct professor of ophthalmology at the University of Minnesota and past chairman of the medical staff at the Phillips Eye Institute in Minneapolis. Dr. Samuelson was previously president of the American Society of Cataract and Refractive Surgery. He is the recipient of the American Academy of Ophthalmology’s Junior and Senior Achievement Awards honoring contributions made to the Academy’s educational programs. In 2018, Dr. Samuelson was awarded the AAO Lifetime Achievement Award. He also received the “Secretariate Award” for contributions to the AAO annual meeting. Dr. Samuelson has served as an examiner for the American Board of Ophthalmology and has been named as one of America’s Top Doctors each year since 2002. Dr. Samuelson served on the executive committee of the American Glaucoma Society for nearly a decade. As a member of the Basic Clinical Science Course Committee for the AAO, Dr. Samuelson helped to write the textbooks most studied by residents within the field of ophthalmology. Dr. Samuelson is the glaucoma section editor for Ocular Surgery News and serves as editorial board member and scientific reviewer for several other ophthalmology journals.

Inder Paul Singh, M.D.

Inder Paul Singh, M.D.

Dr. I. Paul Singh, a Wisconsin native, is the President of The Eye Centers of Racine & Kenosha, Ltd., founded in 1981 by his father, Dr. Kanwar A. Singh. He was a chief resident and completed his residency at Cook County Hospital – Division of Ophthalmology, and his internship at Michael Reese Hospital – Department of Medicine, both in Chicago, Illinois. He graduated from Finch University of Health Sciences/The Chicago Medical School in 1999. His undergraduate education was completed at Washington University in St. Louis, with a B.A. in Biology and Psychology. He completed his fellowship in Glaucoma at Duke University in July 2004 before returning back to his hometown where he is currently in private practice.

Throughout his Ophthalmology career, Dr. Singh has been involved with clinical research and has published papers in several ophthalmology journals. He has also presented his research at various national meetings and universities around the world. He maintains a full time research facility and is currently is involved in industry sponsored and independent research in glaucoma, cataract, ocular surface disease, and retina. He has a strong passion for new technology. He was the first surgeon in Wisconsin to perform many of the minimally invasive glaucoma surgeries (MIGS), such as the iStent, Cypass, Hydrus, and Kahook Dual Blade goniotomy. He is the first to use newer in-office YAG lasers to remove visually significant floaters (YAG Vireolysis) and has helped to develop the protocol for this procedure. Recently, he was instrumental in bringing laser assisted cataract surgery to the area. Recently Newsweek named Dr. Singh America’s Best Eye Doctor in 2021 for quality of care, continuity of care, and the quality of the technology used in his practice.

Medical Optometry

Doug Devries, O.D.

Doug Devries, O.D.

Douglas Devries, O.D. is the co-founder of Eye Care Associates of Nevada and Associate Clinical Professor of Optometry. He is the director of the optometric residency program and is an Associate Clinical Professor of Optometry. Dr Devries graduated with a degree in financial management from the University of Nevada and received his Doctor of Optometry degree from Pacific University. Dr. Devries has participated in numerous clinical trials and has published over 500 national and international meeting presentations, lectures, abstracts, and scientific papers. He is an advisor and speaker for some of the largest ophthalmic pharmaceutical and device companies. He is a clinical investigator in Ocuphire's MIRA-3 Phase 3 clinical trial.

Paul Karpecki, O.D., FAAO

Paul Karpecki, O.D., FAAO

Dr. Karpecki received his doctor of optometry degree from Indiana University and completed a fellowship in Cornea in Kansas City in affiliation with the Pennsylvania College of Optometry.  He currently serves as Director of Cornea Services for Kentucky Eye Institute in Lexington KY, Gaddie Eye Centers in Louisville KY, Midwest Center for Sight in Carmel IN.  He is the Chief Medical Editor for Review of Optometry, chairman of the NTT Conferences and heads the journal’s clinical content.  He is Medical Director for KEPLR Vision and for the Dry Eye Institutes of Kentucky and Indiana.  He was appointed co-chair for the previous two Tear Film and Ocular Surface Society Symposia and served on the DEWS II Diagnostic Methodology Committee.  In 2017-2018 he completed a full year preceptorship in advanced retinal disease at Retina Associates of Kentucky, one of the top 20 retina programs in the country. He currently serves as an Associate Professor at the Kentucky College of Optometry and on the board for the charitable organization Optometry Giving Sight.

Selina McGee, O.D.

Selina McGee, O.D.

Dr. McGee is the visionary founder of Precision Vision of Edmond, a boutique-style eyecare practice that specializes in dry eye disease, specialty contact lenses, and aesthetics. She is also the co-founder of Precision Vision of Midwest City, an MD-OD practice specializing in premium IOL and cataract surgery. She earned her OD degree from Northeastern State University College of Optometry, graduating Summa Cum Laude. She is a member of the Oklahoma Association of Optometric Physicians and the American Optometric Association.  Currently she serves as the Immediate Past-President the OAOP. She is also an adjunct faculty member of Northeastern State University College of Optometry. She was named Young Optometrist of the year in 2012 by the OAOP.

Leslie O’Dell, O.D.

Leslie O’Dell, O.D.

Medical Director of MOA-Shrewsbury, Leslie O’Dell, OD, FAAO, focuses on the management of ocular disease including glaucoma, dry eye, diabetic eye disease, and age-related macular degeneration. Dr. O’Dell graduated from Salus University (formerly Pennsylvania College of Optometry) in 2003 and completed a residency at the Baltimore VA Hospital, one of the premier residency sites in the nation. Throughout her career, Dr. O’Dell has demonstrated her commitment to optimizing patient outcomes through her personalized approach to eye care. She is equally passionate about advancing the field of Optometry and leaving her mark through a wide variety of research endeavors aimed at improving the testing and treatment of ocular diseases.

Dr. O’Dell is a fellow in the American Academy of Optometry, a diplomate of the American Board of Optometry, and a member of the board of directors of the Optometric Glaucoma Foundation. She is a member of the Pennsylvania Optometric Association, Optometric Glaucoma Society, and Tear Film & Ocular Surface Society (TFOS). She was selected to participate in the TFOS Dry Eye Workshop (TFOS DEWSII) initiative in 2017 and is actively participating in the TFOS Global Workshop: “A Lifestyle Epidemic: Ocular Surface Disease.” She is one of six TFOS Global Ambassadors for the United States. Dr. O’Dell is a founding member and current board member of the Intrepid Eye Society.

Throughout her career, Dr. O’Dell has been active in designing, conducting and presenting results for a variety of clinical research studies, including FDA trials and Phase III and Phase IV studies, that have advanced testing and treatment methodologies for a variety of ocular diseases and dry eye management. She currently serves as Director of Clinical Research for MOA and is highly sought-after clinical lecturer by medical device and pharmaceutical companies.

Dr. Leslie O’Dell was named on Newsweek’s “America’s Best Eye Doctors 2022.” She was also named by Primary Care Optometry News to the inaugural “PCON 250” list recognizing excellence in patient care and innovation in the field of Optometry. She was honored by the Central Pennsylvania Optometric Society as “Young OD of the Year” and “OD of the Year.” The Central Penn Business Journal named Dr. O’Dell to its “40 Under 40 list” in 2016 and the “Healthcare Power 30 list” in 2021.

Widely recognized as a thought leader on topics such as advancements in management of dry eye disease, glaucoma, diabetic eye disease, and the management of surgical patients, Dr. O’Dell has lectured nationally and internationally on a variety of topics and has published more than 75 articles in national eye care journals. She is currently Co-Chief Medical Editor for Modern Optometry.

Justin Schweitzer, O.D.

Justin Schweitzer, O.D.

Dr. Justin Schweitzer specializes in advanced glaucoma, refractive surgical clinical care, and anterior segment pathology at Vance Thompson Vision. He received his professional training and Doctor of Optometry degree from Pacific University College of Optometry in Forest Grove, OR.

In 2012, he pursued his dream to focus on glaucoma, advanced anterior segment surgery care and pathology, joining Vance Thompson Vision in Sioux Falls, South Dakota. He earned Fellowship in the American Academy of Optometry in 2013, is the Optometric Externship Director at Vance Thompson Vision, and Adjunct Clinical Professor of the Illinois College of Optometry and Kentucky College of Optometry.

Dr. Schweitzer regularly lectures on glaucoma, anterior segment pathology, refractive surgical clinical care, and surgical management at state, regional, and national meetings. He is currently the Chief Medical Editor for Modern Optometry and has contributed book chapters, journal articles, and case studies in peer reviewed and non-peer reviewed journals including Review of OptometryOptometry TimesPrimary Care Optometry NewsOptometric ManagementThe Journal of Cataract and Refractive SurgeryClinical Ophthalmology, and The Journal of Glaucoma. He has research interests in minimally invasive glaucoma surgery and biomechanical properties of the cornea as it relates to glaucoma.

Dr. Schweitzer is an advocate of an integrated eye care delivery model and is currently serving as a board member for the South Dakota Optometric Society. He also serves as a board member of the Optometric Glaucoma Society, a member of the American Optometric Association; Optometric Cornea, Cataract, and Refractive Society; Scleral Lens Education Society; Intrepid Eye Society; and is actively involved in his community’s eye care initiatives.